2018 · Journal of global health reports · paywalled
Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population
Hernandez et al.
The finding, in our words
Urine self-sampling detected high-risk HPV with 51% sensitivity and 96% specificity compared to clinician-collected cervical samples, showing moderate overall agreement but substantial agreement in women aged 40 and older. This indicates urine testing could serve as a viable screening tool in low-resource settings where clinical collection is challenging, particularly for older women.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.